Skip to content

SEYLAN: value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

SEYLAN

BE 0886.790.826
NACE 56.112, Limited-service restaurants, excluding mobile food services
latest balance sheet 31-12-2025indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€11,768 to €22,707

Midpoint €16,326 · 50% capitalised earnings, 50% adjusted equity

Adjusted equity -€31,156
Capitalised earnings €54,693 to €76,570
Indication €11,768 to €22,707

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€31,156
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€31,156

Capitalised earnings

net result for the year (9904)
2025
€9,752
2024
€9,034
2023
€4,186
2022
€12,229
2021
€21,795
Average result
€7,657
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€54,693 / €63,808 / €76,570

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 31 December 2025. Prepared on 29 September 2026 via checked.be. Indication, not a valuation or advice.